These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1092 related items for PubMed ID: 35595223

  • 1. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles.
    Zhou C, Yang X, Wang Y, Xi J, Pan H, Wang M, Zhou Y, Xiao Y.
    Hum Reprod; 2022 Jul 30; 37(8):1795-1805. PubMed ID: 35595223
    [Abstract] [Full Text] [Related]

  • 2. Does an FSH surge at the time of hCG trigger improve IVF/ICSI outcomes? A randomized, double-blinded, placebo-controlled study.
    Qiu Q, Huang J, Li Y, Chen X, Lin H, Li L, Yang D, Wang W, Zhang Q.
    Hum Reprod; 2020 Jun 01; 35(6):1411-1420. PubMed ID: 32383771
    [Abstract] [Full Text] [Related]

  • 3. A modified flexible GnRH antagonist protocol using antagonist early cessation and a gonadotropin step-down approach improves live birth rates in fresh cycles: a randomized controlled trial.
    Xu B, Geerts D, Yuan J, Wang M, Li Z, Lai Q, Zheng Y, Liu S, Yang S, Zhu G, Jin L.
    Hum Reprod; 2024 Sep 01; 39(9):1969-1978. PubMed ID: 38942602
    [Abstract] [Full Text] [Related]

  • 4. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
    Yılmaz N, Ceran MU, Ugurlu EN, Gülerman HC, Engin Ustun Y.
    J Obstet Gynaecol; 2020 Aug 01; 40(6):837-842. PubMed ID: 31791167
    [Abstract] [Full Text] [Related]

  • 5. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
    Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, Aboulfoutouh I, van Wely M.
    Cochrane Database Syst Rev; 2014 Oct 31; 2014(10):CD008046. PubMed ID: 25358904
    [Abstract] [Full Text] [Related]

  • 6. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, Prætorius L, Zedeler A, Nilas L, Pinborg A.
    Hum Reprod; 2016 Jun 31; 31(6):1253-64. PubMed ID: 27060174
    [Abstract] [Full Text] [Related]

  • 7. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
    Xu B, Geerts D, Hu S, Yue J, Li Z, Zhu G, Jin L.
    Hum Reprod; 2020 Jun 01; 35(6):1306-1318. PubMed ID: 32478400
    [Abstract] [Full Text] [Related]

  • 8. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
    Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY.
    Hum Reprod; 2013 Sep 01; 28(9):2511-21. PubMed ID: 23753114
    [Abstract] [Full Text] [Related]

  • 9. The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF/ICSI for high responders: a randomized controlled trial.
    Santos-Ribeiro S, Mackens S, Popovic-Todorovic B, Racca A, Polyzos NP, Van Landuyt L, Drakopoulos P, de Vos M, Tournaye H, Blockeel C.
    Hum Reprod; 2020 Dec 01; 35(12):2808-2818. PubMed ID: 32964939
    [Abstract] [Full Text] [Related]

  • 10. Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves in vitro fertilisation outcomes in poor ovarian responders.
    Mutlu I, Demirdag E, Cevher F, Erdem A, Erdem M.
    J Obstet Gynaecol; 2022 Jul 01; 42(5):1239-1244. PubMed ID: 34565274
    [Abstract] [Full Text] [Related]

  • 11. Reproductive Outcome After GnRH Agonist Triggering With Co-Administration of 1500 IU hCG on the Day of Oocyte Retrieval in High Responders: A Long-Term Retrospective Cohort Study.
    Abdulkhalikova D, Bokal EV, Stimpfel M, Ciglar P, Korosec S.
    Front Endocrinol (Lausanne); 2022 Jul 01; 13():826411. PubMed ID: 35464066
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study.
    Haas J, Bassil R, Samara N, Zilberberg E, Mehta C, Orvieto R, Casper RF.
    Hum Reprod; 2020 Jul 01; 35(7):1648-1654. PubMed ID: 32563188
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.
    Bülow NS, Warzecha AK, Nielsen MV, Andersen CY, Holt MD, Petersen MR, Sopa N, Zedeler A, Englund AL, Pinborg A, Grøndahl ML, Skouby SO, Macklon NS.
    Hum Reprod; 2023 Nov 02; 38(11):2154-2165. PubMed ID: 37699851
    [Abstract] [Full Text] [Related]

  • 19. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
    Orvieto R.
    J Ovarian Res; 2015 Nov 04; 8():69. PubMed ID: 26536862
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.